Skip to main content
Joseph Burns, MD, Neurology, Burlington, MA

JosephDanielBurnsMD

Neurology Burlington, MA

Vascular Neurology, Neurocritical Care

Director of Neurocritical Care, Lahey Hospital and Medical Center

Dr. Burns is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Burns' full profile

Already have an account?

  • Office

    41 Mall Rd
    # Lahey
    Burlington, MA 01805
    Phone+1 781-744-8630
    Fax+1 781-744-5581

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Neurocritical Care, 2008 - 2009
  • Mayo Clinic College of Medicine and Science
    Mayo Clinic College of Medicine and ScienceFellowship, Vascular Neurology, 2007 - 2008
  • Tufts Medical Center
    Tufts Medical CenterResidency, Neurology, 2004 - 2007
  • Lahey Clinic
    Lahey ClinicInternship, Internal Medicine, 2003 - 2004
  • University of Massachusetts Medical School
    University of Massachusetts Medical SchoolClass of 2003

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2009 - 2026
  • NH State Medical License
    NH State Medical License 2024 - 2026
  • MN State Medical License
    MN State Medical License 2007 - 2010
  • American Board of Psychiatry and Neurology Neurology
  • United Council of Neurologic SubspecialtiesNeurocritical Care

Publications & Presentations

PubMed

Press Mentions

  • Why It’s Important to Cover Hospitals Suing Patients over Medical Debt
    Why It’s Important to Cover Hospitals Suing Patients over Medical DebtDecember 30th, 2022
  • Why You Should Cover the Slow COVID-19 Vaccine Rollout and Insurance Concerns
    Why You Should Cover the Slow COVID-19 Vaccine Rollout and Insurance ConcernsOctober 4th, 2023